Beta-sitosterol: a promising but orphan nutraceutical to fight against cancer

MS Bin Sayeed, SS Ameen - Nutrition and cancer, 2015 - Taylor & Francis
All the currently available cancer therapeutic options are expensive but none of them are
safe. However, traditional plant-derived medicines or compounds are relatively safe. One …

[HTML][HTML] Critical analysis on characterization, systemic effect, and therapeutic potential of beta-sitosterol: a plant-derived orphan phytosterol

MS Bin Sayeed, SMR Karim, T Sharmin, MM Morshed - Medicines, 2016 - mdpi.com
Beta-sitosterol (BS) is a phytosterol, widely distributed throughout the plant kingdom and
known to be involved in the stabilization of cell membranes. To compile the sources …

[HTML][HTML] Thymoquinone as a potential adjuvant therapy for cancer treatment: evidence from preclinical studies

AGM Mostofa, MK Hossain, D Basak… - Frontiers in …, 2017 - frontiersin.org
Thymoquinone (TQ), the main bioactive component of Nigella sativa, has been found to
exhibit anticancer effects in numerous preclinical studies. Due to its multitargeting nature, TQ …

[HTML][HTML] Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

CJL Murray, AY Aravkin, P Zheng, C Abbafati… - The lancet, 2020 - thelancet.com
Background Rigorous analysis of levels and trends in exposure to leading risk factors and
quantification of their effect on human health are important to identify where public health is …

[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017 …

SL James, D Abate, KH Abate, SM Abay, C Abbafati… - The Lancet, 2018 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and …

[HTML][HTML] Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the …

GA Roth, D Abate, KH Abate, SM Abay, C Abbafati… - The lancet, 2018 - thelancet.com
Background Global development goals increasingly rely on country-specific estimates for
benchmarking a nation's progress. To meet this need, the Global Burden of Diseases …

[HTML][HTML] Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 …

JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate… - The Lancet, 2018 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
(GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor …

[HTML][HTML] Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

CO Johnson, M Nguyen, GA Roth, E Nichols… - The Lancet …, 2019 - thelancet.com
Background Stroke is a leading cause of mortality and disability worldwide and the
economic costs of treatment and post-stroke care are substantial. The Global Burden of …

[HTML][HTML] Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study …

E Nichols, CEI Szoeke, SE Vollset, N Abbasi… - The Lancet …, 2019 - thelancet.com
Background The number of individuals living with dementia is increasing, negatively
affecting families, communities, and health-care systems around the world. A successful …

[HTML][HTML] Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and …

HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati… - The Lancet, 2018 - thelancet.com
Background How long one lives, how many years of life are spent in good and poor health,
and how the population's state of health and leading causes of disability change over time …